ALPS Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
ALPS Advisors's FLGT Position: Q3 2026 in Review
ALPS Advisors increased its Fulgent Genetics (FLGT) stake by 26% in Q3 2026, buying an estimated $148K and bringing the position to 36,199 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #744.
ALPS Advisors first reported a position in FLGT in Q1 2021 and has held it in 14 quarters since. 47 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- ALPS Advisors held 36,199 shares of Fulgent Genetics worth $797K as of Q3 2026.
- ALPS Advisors bought 7,375 Fulgent Genetics shares in Q3 2026, an estimated $148K.
- Fulgent Genetics made up ﹤0.01% of ALPS Advisors's portfolio in Q3 2026, its #744 holding.
- ALPS Advisors first reported a position in Fulgent Genetics in Q1 2021 and has held it in 14 quarters since.
- 47 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.